Health + Wellness

FDA Approved Technology Could Be a Big Win for Prostate Cancer Patients

new prostate cancer technology

New FDA-approved technology could be a significant win for prostate cancer patients across the US. With this innovation, patients may be able to get the treatment they need much sooner.

Scientists have been making strides in battling the disease in recent years, and this new addition could be the boost we need to get to a final solution. At the very least, it will aid millions nationwide with getting proper treatment.

As you may know, Blacks, particularly men, have a higher incidence and mortality of prostate cancer. Well, it seems the FDA has taken one more step toward making sure we live a longer, much healthier life.

What Did the FDA Approve?

Not too long ago, the FDA approved new software for MRI machines that can potentially detect prostate cancer within patients. A small company developed the technology in Nebraska whose CEO is ecstatic about the latest contribution. 

The CEO, Randall Jones, highlighted the plight many men face while fighting prostate cancer and its lack of progress within the past 30 years. However, with his company’s new product, this unfortunate circumstance might disappear over time.

The new software utilizes AI to pinpoint specific prostate cancer markers within MRI scans. The bot will recognize the tumor’s cells and measure the volume to assess how detrimental it could be to the person’s health.

RELATED: Why Black Men Should Consider Immunotherapy for Prostate Cancer

How This new MRI Software Could Help

This new software will be a massive help for prostate cancer patients because early detection is so important. If the AI can spot cancerous tumors that would be otherwise too small to detect through a regular checkup, there’s a better chance a doctor can catch them.

Furthermore, it will help radiologists assess lesions within the prostate better than before, allowing them to determine cancer potential more accurately. After all, studies have shown that artificial intelligence is much better at screening cancer cells on MRI images than humans.

How Accessible This Technology Will Be

With FDA clearance, the company believes that the pathway toward implementing this technology inside all MRI machines is

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button